Cyclo Therapeutics, Inc. (CYTHW) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - Specialty & Generic industria. La empresa tiene su sede en Gainesville, FL, United States. El CEO actual es N. Scott Fine.
CYTHW tiene fecha de IPO 2020-12-18, 8 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $899.37K.
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
